Connection

Steven Carroll to Humans

This is a "connection" page, showing publications Steven Carroll has written about Humans.
Connection Strength

0.892
  1. R-Ras subfamily proteins elicit distinct physiologic effects and phosphoproteome alterations in neurofibromin-null MPNST cells. Cell Commun Signal. 2021 09 16; 19(1):95.
    View in: PubMed
    Score: 0.031
  2. The RASopathies: Biology, genetics and therapeutic options. Adv Cancer Res. 2022; 153:305-341.
    View in: PubMed
    Score: 0.031
  3. The Role of R-Ras Proteins in Normal and Pathologic Migration and Morphologic Change. Am J Pathol. 2021 09; 191(9):1499-1510.
    View in: PubMed
    Score: 0.030
  4. Establishment and genomic characterization of a sporadic malignant peripheral nerve sheath tumor cell line. Sci Rep. 2021 03 11; 11(1):5690.
    View in: PubMed
    Score: 0.030
  5. Salinomycin targets the genome of radioresistant cells in glioblastomas. Neuro Oncol. 2020 02 20; 22(2):167-168.
    View in: PubMed
    Score: 0.028
  6. Mechanisms of Receptor Tyrosine-Protein Kinase ErbB-3 (ERBB3) Action in Human Neoplasia. Am J Pathol. 2019 10; 189(10):1898-1912.
    View in: PubMed
    Score: 0.027
  7. ErbB4 promotes malignant peripheral nerve sheath tumor pathogenesis via Ras-independent mechanisms. Cell Commun Signal. 2019 07 10; 17(1):74.
    View in: PubMed
    Score: 0.027
  8. Complex Patterns of GABAergic Neuronal Deficiency and Type 2 Potassium-Chloride Cotransporter Immaturity in Human Focal Cortical Dysplasia. J Neuropathol Exp Neurol. 2019 04 01; 78(4):365-372.
    View in: PubMed
    Score: 0.026
  9. Recent Advances in the Diagnosis and Pathogenesis of Neurofibromatosis Type 1 (NF1)-associated Peripheral Nervous System Neoplasms. Adv Anat Pathol. 2018 Sep; 25(5):353-368.
    View in: PubMed
    Score: 0.025
  10. The Molecular and Morphologic Structures That Make Saltatory Conduction Possible in Peripheral Nerve. J Neuropathol Exp Neurol. 2017 04 01; 76(4):255-257.
    View in: PubMed
    Score: 0.023
  11. The Challenge of Cancer Genomics in Rare Nervous System Neoplasms: Malignant Peripheral Nerve Sheath Tumors as a Paradigm for Cross-Species Comparative Oncogenomics. Am J Pathol. 2016 Mar; 186(3):464-77.
    View in: PubMed
    Score: 0.021
  12. Classic Ras Proteins Promote Proliferation and Survival via Distinct Phosphoproteome Alterations in Neurofibromin-Null Malignant Peripheral Nerve Sheath Tumor Cells. J Neuropathol Exp Neurol. 2015 Jun; 74(6):568-86.
    View in: PubMed
    Score: 0.020
  13. Neuregulin-1 overexpression and Trp53 haploinsufficiency cooperatively promote de novo malignant peripheral nerve sheath tumor pathogenesis. Acta Neuropathol. 2014 Apr; 127(4):573-91.
    View in: PubMed
    Score: 0.018
  14. Missense variant in TREML2 protects against Alzheimer's disease. Neurobiol Aging. 2014 Jun; 35(6):1510.e19-26.
    View in: PubMed
    Score: 0.018
  15. GWAS of cerebrospinal fluid tau levels identifies risk variants for Alzheimer's disease. Neuron. 2013 Apr 24; 78(2):256-68.
    View in: PubMed
    Score: 0.017
  16. Malignant peripheral nerve sheath tumor invasion requires aberrantly expressed EGF receptors and is variably enhanced by multiple EGF family ligands. J Neuropathol Exp Neurol. 2013 Mar; 72(3):219-33.
    View in: PubMed
    Score: 0.017
  17. Transgenic mice overexpressing neuregulin-1 model neurofibroma-malignant peripheral nerve sheath tumor progression and implicate specific chromosomal copy number variations in tumorigenesis. Am J Pathol. 2013 Mar; 182(3):646-67.
    View in: PubMed
    Score: 0.017
  18. Evidence for a role of the rare p.A152T variant in MAPT in increasing the risk for FTD-spectrum and Alzheimer's diseases. Hum Mol Genet. 2012 Aug 01; 21(15):3500-12.
    View in: PubMed
    Score: 0.016
  19. Parsing out reality from genetically engineered mouse models of neurologic diseases. Brain Res Bull. 2012 May 01; 88(1):1-2.
    View in: PubMed
    Score: 0.016
  20. Molecular mechanisms promoting the pathogenesis of Schwann cell neoplasms. Acta Neuropathol. 2012 Mar; 123(3):321-48.
    View in: PubMed
    Score: 0.016
  21. Genetically engineered mouse models shed new light on the pathogenesis of neurofibromatosis type I-related neoplasms of the peripheral nervous system. Brain Res Bull. 2012 May 01; 88(1):58-71.
    View in: PubMed
    Score: 0.015
  22. Orthotopic xenografting of human luciferase-tagged malignant peripheral nerve sheath tumor cells for in vivo testing of candidate therapeutic agents. J Vis Exp. 2011 Mar 07; (49).
    View in: PubMed
    Score: 0.015
  23. Tamoxifen inhibits malignant peripheral nerve sheath tumor growth in an estrogen receptor-independent manner. Neuro Oncol. 2011 Jan; 13(1):28-41.
    View in: PubMed
    Score: 0.015
  24. Neuregulin-1 beta and neuregulin-1 alpha differentially affect the migration and invasion of malignant peripheral nerve sheath tumor cells. Glia. 2009 Nov 01; 57(14):1501-20.
    View in: PubMed
    Score: 0.014
  25. How does the Schwann cell lineage form tumors in NF1? Glia. 2008 Nov 01; 56(14):1590-1605.
    View in: PubMed
    Score: 0.013
  26. Alzheimer's Disease Risk Polymorphisms Regulate Gene Expression in the ZCWPW1 and the CELF1 Loci. PLoS One. 2016; 11(2):e0148717.
    View in: PubMed
    Score: 0.010
  27. Neuregulin growth factors and their ErbB receptors form a potential signaling network for schwannoma tumorigenesis. J Neuropathol Exp Neurol. 2006 Feb; 65(2):162-75.
    View in: PubMed
    Score: 0.010
  28. Discovery of gene-gene interactions across multiple independent data sets of late onset Alzheimer disease from the Alzheimer Disease Genetics Consortium. Neurobiol Aging. 2016 Feb; 38:141-150.
    View in: PubMed
    Score: 0.010
  29. Activation of the neuregulin-1/ErbB signaling pathway promotes the proliferation of neoplastic Schwann cells in human malignant peripheral nerve sheath tumors. Oncogene. 2005 Aug 25; 24(36):5589-605.
    View in: PubMed
    Score: 0.010
  30. Tumor suppressor mutations and growth factor signaling in the pathogenesis of NF1-associated peripheral nerve sheath tumors: II. The role of dysregulated growth factor signaling. J Neuropathol Exp Neurol. 2005 Jan; 64(1):1-9.
    View in: PubMed
    Score: 0.010
  31. Tumor suppressor mutations and growth factor signaling in the pathogenesis of NF1-associated peripheral nerve sheath tumors. I. The role of tumor suppressor mutations. J Neuropathol Exp Neurol. 2004 Nov; 63(11):1115-23.
    View in: PubMed
    Score: 0.010
  32. Two rare AKAP9 variants are associated with Alzheimer's disease in African Americans. Alzheimers Dement. 2014 Nov; 10(6):609-618.e11.
    View in: PubMed
    Score: 0.009
  33. Constitutive activation of the neuregulin-1/erbB signaling pathway promotes the proliferation of a human peripheral neuroepithelioma cell line. J Neurooncol. 2004 Feb; 66(3):273-84.
    View in: PubMed
    Score: 0.009
  34. TREM2 and neurodegenerative disease. N Engl J Med. 2013 10 17; 369(16):1564-5.
    View in: PubMed
    Score: 0.009
  35. SORL1 is genetically associated with late-onset Alzheimer's disease in Japanese, Koreans and Caucasians. PLoS One. 2013; 8(4):e58618.
    View in: PubMed
    Score: 0.009
  36. Neuregulin-1 and erbB4 immunoreactivity is associated with neuritic plaques in Alzheimer disease brain and in a transgenic model of Alzheimer disease. J Neuropathol Exp Neurol. 2003 Jan; 62(1):42-54.
    View in: PubMed
    Score: 0.008
  37. Suppression of Fli-1 protects against pericyte loss and cognitive deficits in Alzheimer's disease. Mol Ther. 2022 04 06; 30(4):1451-1464.
    View in: PubMed
    Score: 0.008
  38. The Potential Role of Small-Molecule PERK Inhibitor LDN-0060609 in Primary Open-Angle Glaucoma Treatment. Int J Mol Sci. 2021 Apr 26; 22(9).
    View in: PubMed
    Score: 0.008
  39. Each patient is a research biorepository: informatics-enabled research on surplus clinical specimens via the living BioBank. J Am Med Inform Assoc. 2021 01 15; 28(1):138-143.
    View in: PubMed
    Score: 0.007
  40. Chemoembolizing hepatocellular carcinoma with microsphere cored with arsenic trioxide microcrystal. Drug Deliv. 2020 Nov 26; 27(1):1729-1740.
    View in: PubMed
    Score: 0.007
  41. Receptors for pro-resolving mediators are increased in Alzheimer's disease brain. Brain Pathol. 2020 05; 30(3):614-640.
    View in: PubMed
    Score: 0.007
  42. Serum pro-BDNF levels correlate with phospho-tau staining in Alzheimer's disease. Neurobiol Aging. 2020 03; 87:49-59.
    View in: PubMed
    Score: 0.007
  43. The Proteome of the Dentate Terminal Zone of the Perforant Path Indicates Presynaptic Impairment in Alzheimer Disease. Mol Cell Proteomics. 2020 01; 19(1):128-141.
    View in: PubMed
    Score: 0.007
  44. The evolution and multi-molecular properties of NF1 cutaneous neurofibromas originating from C-fiber sensory endings and terminal Schwann cells at normal sites of sensory terminations in the skin. PLoS One. 2019; 14(5):e0216527.
    View in: PubMed
    Score: 0.007
  45. Usp9X Regulates Cell Death in Malignant Peripheral Nerve Sheath Tumors. Sci Rep. 2018 11 26; 8(1):17390.
    View in: PubMed
    Score: 0.006
  46. Cutaneous neurofibromas: Current clinical and pathologic issues. Neurology. 2018 07 10; 91(2 Suppl 1):S5-S13.
    View in: PubMed
    Score: 0.006
  47. Analysis of shared heritability in common disorders of the brain. Science. 2018 06 22; 360(6395).
    View in: PubMed
    Score: 0.006
  48. Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease. Nat Genet. 2017 09; 49(9):1373-1384.
    View in: PubMed
    Score: 0.006
  49. Transethnic genome-wide scan identifies novel Alzheimer's disease loci. Alzheimers Dement. 2017 Jul; 13(7):727-738.
    View in: PubMed
    Score: 0.006
  50. BH3 mimetics suppress CXCL12 expression in human malignant peripheral nerve sheath tumor cells. Oncotarget. 2017 Jan 31; 8(5):8670-8678.
    View in: PubMed
    Score: 0.006
  51. Neuronal exosomes reveal Alzheimer's disease biomarkers in Down syndrome. Alzheimers Dement. 2017 May; 13(5):541-549.
    View in: PubMed
    Score: 0.005
  52. Neuropathy of metachromatic leukodystrophy: improvement with immunomodulation. Pediatr Neurol. 1996 Oct; 15(3):237-9.
    View in: PubMed
    Score: 0.005
  53. Current status and recommendations for biomarkers and biobanking in neurofibromatosis. Neurology. 2016 Aug 16; 87(7 Suppl 1):S40-8.
    View in: PubMed
    Score: 0.005
  54. Assessment of the genetic variance of late-onset Alzheimer's disease. Neurobiol Aging. 2016 May; 41:200.e13-200.e20.
    View in: PubMed
    Score: 0.005
  55. The executive prominent/memory prominent spectrum in Alzheimer's disease is highly heritable. Neurobiol Aging. 2016 May; 41:115-121.
    View in: PubMed
    Score: 0.005
  56. STAT1 and NF-?B Inhibitors Diminish Basal Interferon-Stimulated Gene Expression and Improve the Productive Infection of Oncolytic HSV in MPNST Cells. Mol Cancer Res. 2016 05; 14(5):482-92.
    View in: PubMed
    Score: 0.005
  57. Overexpression of GAB2 in ovarian cancer cells promotes tumor growth and angiogenesis by upregulating chemokine expression. Oncogene. 2016 08 04; 35(31):4036-47.
    View in: PubMed
    Score: 0.005
  58. Association of Long Runs of Homozygosity With Alzheimer Disease Among African American Individuals. JAMA Neurol. 2015 Nov; 72(11):1313-23.
    View in: PubMed
    Score: 0.005
  59. Interaction between variants in CLU and MS4A4E modulates Alzheimer's disease risk. Alzheimers Dement. 2016 Feb; 12(2):121-129.
    View in: PubMed
    Score: 0.005
  60. Associations between Potentially Modifiable Risk Factors and Alzheimer Disease: A Mendelian Randomization Study. PLoS Med. 2015 Jun; 12(6):e1001841; discussion e1001841.
    View in: PubMed
    Score: 0.005
  61. Global and local ancestry in African-Americans: Implications for Alzheimer's disease risk. Alzheimers Dement. 2016 Mar; 12(3):233-43.
    View in: PubMed
    Score: 0.005
  62. Genetically predicted body mass index and Alzheimer's disease-related phenotypes in three large samples: Mendelian randomization analyses. Alzheimers Dement. 2015 Dec; 11(12):1439-1451.
    View in: PubMed
    Score: 0.005
  63. A novel Alzheimer disease locus located near the gene encoding tau protein. Mol Psychiatry. 2016 Jan; 21(1):108-17.
    View in: PubMed
    Score: 0.005
  64. Rarity of the Alzheimer disease-protective APP A673T variant in the United States. JAMA Neurol. 2015 Feb; 72(2):209-16.
    View in: PubMed
    Score: 0.005
  65. A rare mutation in UNC5C predisposes to late-onset Alzheimer's disease and increases neuronal cell death. Nat Med. 2014 Dec; 20(12):1452-7.
    View in: PubMed
    Score: 0.005
  66. Effects of multiple genetic loci on age at onset in late-onset Alzheimer disease: a genome-wide association study. JAMA Neurol. 2014 Nov; 71(11):1394-404.
    View in: PubMed
    Score: 0.005
  67. Genome-wide association meta-analysis of neuropathologic features of Alzheimer's disease and related dementias. PLoS Genet. 2014 Sep; 10(9):e1004606.
    View in: PubMed
    Score: 0.005
  68. Assessment of oncolytic HSV efficacy following increased entry-receptor expression in malignant peripheral nerve sheath tumor cell lines. Gene Ther. 2014 Nov; 21(11):984-90.
    View in: PubMed
    Score: 0.005
  69. BNIP3 regulates AT101 [(-)-gossypol] induced death in malignant peripheral nerve sheath tumor cells. PLoS One. 2014; 9(5):e96733.
    View in: PubMed
    Score: 0.005
  70. ABCC9 gene polymorphism is associated with hippocampal sclerosis of aging pathology. Acta Neuropathol. 2014; 127(6):825-43.
    View in: PubMed
    Score: 0.005
  71. Alzheimer's disease: analyzing the missing heritability. PLoS One. 2013; 8(11):e79771.
    View in: PubMed
    Score: 0.004
  72. Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease. Nat Genet. 2013 Dec; 45(12):1452-8.
    View in: PubMed
    Score: 0.004
  73. 4-Hydroxytamoxifen induces autophagic death through K-Ras degradation. Cancer Res. 2013 Jul 15; 73(14):4395-405.
    View in: PubMed
    Score: 0.004
  74. Independent and epistatic effects of variants in VPS10-d receptors on Alzheimer disease risk and processing of the amyloid precursor protein (APP). Transl Psychiatry. 2013 May 14; 3:e256.
    View in: PubMed
    Score: 0.004
  75. Variants in the ATP-binding cassette transporter (ABCA7), apolipoprotein E ?4,and the risk of late-onset Alzheimer disease in African Americans. JAMA. 2013 Apr 10; 309(14):1483-92.
    View in: PubMed
    Score: 0.004
  76. Genome-wide association study of the rate of cognitive decline in Alzheimer's disease. Alzheimers Dement. 2014 Jan; 10(1):45-52.
    View in: PubMed
    Score: 0.004
  77. Initial assessment of the pathogenic mechanisms of the recently identified Alzheimer risk Loci. Ann Hum Genet. 2013 Mar; 77(2):85-105.
    View in: PubMed
    Score: 0.004
  78. Common genetic variants in the CLDN2 and PRSS1-PRSS2 loci alter risk for alcohol-related and sporadic pancreatitis. Nat Genet. 2012 Dec; 44(12):1349-54.
    View in: PubMed
    Score: 0.004
  79. Novel late-onset Alzheimer disease loci variants associate with brain gene expression. Neurology. 2012 Jul 17; 79(3):221-8.
    View in: PubMed
    Score: 0.004
  80. The pan erbB inhibitor PD168393 enhances lysosomal dysfunction-induced apoptotic death in malignant peripheral nerve sheath tumor cells. Neuro Oncol. 2012 Mar; 14(3):266-77.
    View in: PubMed
    Score: 0.004
  81. Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease. Nat Genet. 2011 May; 43(5):436-41.
    View in: PubMed
    Score: 0.004
  82. Liver fatty acid-binding protein: a marker for studying cellular differentiation in gut epithelial neoplasms. Gastroenterology. 1990 Dec; 99(6):1727-35.
    View in: PubMed
    Score: 0.004
  83. Meta-analysis confirms CR1, CLU, and PICALM as alzheimer disease risk loci and reveals interactions with APOE genotypes. Arch Neurol. 2010 Dec; 67(12):1473-84.
    View in: PubMed
    Score: 0.004
  84. Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP-43 inclusions. Nat Genet. 2010 Mar; 42(3):234-9.
    View in: PubMed
    Score: 0.003
  85. Knockout of plasminogen activator inhibitor 1 gene reduces amyloid beta peptide burden in a mouse model of Alzheimer's disease. Neurobiol Aging. 2011 Jun; 32(6):1079-89.
    View in: PubMed
    Score: 0.003
  86. Neuregulin-1 enhances survival of human astrocytic glioma cells. Glia. 2005 Aug 15; 51(3):217-28.
    View in: PubMed
    Score: 0.003
  87. Improved gene delivery into neuroglial cells using a fiber-modified adenovirus vector. Biochem Biophys Res Commun. 2005 Mar 25; 328(4):1182-7.
    View in: PubMed
    Score: 0.002
  88. Neuregulin-1 enhances motility and migration of human astrocytic glioma cells. J Biol Chem. 2003 Jun 06; 278(23):20971-8.
    View in: PubMed
    Score: 0.002
  89. Glutamate transporter EAAT2 splice variants occur not only in ALS, but also in AD and controls. Neurology. 2000 Oct 24; 55(8):1082-8.
    View in: PubMed
    Score: 0.002
  90. Clear cell neoplasms and pseudoneoplastic lesions of the central nervous system. Semin Diagn Pathol. 1997 Nov; 14(4):253-69.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.